Meta-Analysis Evaluating Calcium Channel Blockers and the Risk of Peripheral Arterial Disease in Patients With Hypertension

Meta-analysis of 7 RCTs (n=71,971) found that use of a calcium channel blocker was associated with a 30% reduction in the odds of developing peripheral artery disease vs other antihypertensives or placebo (2% vs 3%, OR 0.70, 95% CI 0.58-0.86).

American Journal of Cardiology